CAPSTONE INVESTMENT ADVISORS, LLC
Position in ANIP — Ani Pharmaceuticals Inc
CIK 1426196
NEW YORK, NY
Position in ANIP
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$922,997
+$179,759 QoQ
Shares Held
11,150
+15.4% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#141
of 303 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ANIP Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CAPSTONE INVESTMENT ADVISORS, LLC holds $5,128,141 across 6 Drug Manufacturers - Specialty & Generic names. ANIP ranks #2 (18.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
35,180 | $2,528,034 | |
| 2 | ANIP |
Ani Pharmaceuticals Inc
This page
|
11,150 | $922,997 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
1,123 | $608,475 | |
| 4 | HIMS |
Hims & Hers Health, Inc.
|
13,568 | $470,402 | |
| 5 | SUPN |
Supernus Pharmaceuticals, Inc.
|
6,902 | $321,012 | |
| 6 | LQDA |
Liquidia Corp
|
3,477 | $277,221 |
All Filings in ANIP
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $922,997 | 11,150 | Shares | Defined | 2026-08-17 | |
| 2026-03-31 | $743,238 | 9,665 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $783,479 | 9,925 | Shares | Defined | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||